Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

First-of-its-kind messenger RNA therapy developed for ovarian cancer, cachexia

Researchers at Oregon State University and Oregon Health & Science University have developed a promising, first-of-its-kind messenger RNA therapy for ovarian cancer as well as cachexia, a muscle-wasting condition associated with cancer and other chronic illnesses.

13 Sep 2022

Study identifies mechanism behind 'cytokine storm' in COVID-19 patient lungs

A new study by HSS Research Institute scientists identifies a mechanism by which SARS-CoV-2 induces the inflammatory response in COVID-19 patient lungs, so-called "cytokine storm", that can lead to lasting tissue damage and poor patient outcomes.

13 Sep 2022

What is the risk of SARS-CoV-2 infection among gout patients?

The main outcome of a new study study was to assess the risk of SARS-CoV-2 infection among gout patients.

12 Sep 2022

Factors influencing patient’s perception during COVID-19 recovery

A team of researchers characterized individual-level illness perception, both cognitive and emotional, following COVID-19.

9 Sep 2022

Supplementary folic acid associated with higher risk of COVID-19 diagnosis and mortality

In a recent study published in the journal BMJ Open, researchers investigated the impact of folic acid supplements and methotrexate, in combination or individually, on disease severity and mortality in coronavirus disease 2019 (COVID-19) cases.

8 Sep 2022

Researchers identify protein that plays a critical role in rheumatoid arthritis damage

Scientists have identified a protein known as sulfatase-2 that plays a critical role in the damage caused by rheumatoid arthritis.

8 Sep 2022

‘It’s becoming too expensive to live’: Anxious older adults try to cope with limited budgets

Economic insecurity is upending the lives of millions of older adults as soaring housing costs and inflation diminish the value of fixed incomes.

7 Sep 2022

Auranofin inhibits SARS-CoV-2 replication

In a new ISCIENCE journal study, scientists identified an FDA-approved NF-κB inhibitor, Auranofin, which can also control inflammation.

6 Sep 2022

Myocarditis cases among young males after COVID-19 vaccines remain rare and mild, study finds

A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after third dose of the Pfizer-BioNTech COVID-19 vaccine, and the cases were rare and mild, according to new research published today in the American Heart Association's flagship journal Circulation.

5 Sep 2022

The origins, breadth, and resolution of autoreactivity in severe COVID-19

Researchers assessed naïve B cells and autoreactivity in severe COVID-19.

2 Sep 2022

Novel method for accurate diagnosis and treatment of uveitis

An estimated five to ten percent of blindness worldwide is caused by the rare inflammatory eye disease uveitis. Posterior uveitis in particular is often associated with severe disease progression and the need for immunosuppressive therapy.

29 Aug 2022

Is there an association between the gut microbiome of people within different countries and the severity of COVID-19?

Researchers explored the complex relationship between the gut microbiome of people in different countries and the observed COVID-19 severity, measured as the hospitalization rate of the corresponding country.

29 Aug 2022

People with autoimmune disorder have a higher risk of developing cardiovascular disease

Around ten percent of the population in high income regions like Europe and the United States has been diagnosed with one or multiple autoimmune disorders.

29 Aug 2022

The incidence rates of adverse events of special interest in COVID-19 vaccinated and non-vaccinated persons

Researchers monitored the safety of the four diverse SARS-CoV-2 vaccines approved by the EMA and MHRA in 2020 to 2021.

24 Aug 2022

Medical cannabis used for chronic pain linked with elevated risk of heart rhythm disorders

Cannabis prescribed for chronic pain is associated with an elevated risk of heart rhythm disorders, according to research presented at ESC Congress 2022.

22 Aug 2022

New treatment may help counteract food allergies and inflammatory diseases in future

Although many people with dietary allergies experience mild symptoms when exposed to triggering foods, some face potentially fatal consequences.

22 Aug 2022

Study reveals safety and uptake of sotrovimab against severe SARS-CoV-2 infection in England

In a newly released study, researchers explored the sotrovimab uptake for severe COVID-19 prophylaxis and its safety across the community populations in England.

22 Aug 2022

Scientists begin phase 2 clinical trials of lupus pill

Lupus is an autoimmune disease that attacks organs and can be fatal. There's no cure, so current treatments aim to limit damage and ameliorate symptoms.

22 Aug 2022

Novel member of a class of anti-diabetes drugs could help treat muscle wasting disease

Inflammatory myopathies can be challenging to treat, but a new study reports encouraging findings for patients with these debilitating conditions. Researchers from Japan have found that a novel member of a class of anti-diabetes drugs could be the key to treating patients with muscle wasting disease.

18 Aug 2022

Adults with low blood urate levels may be at higher risk of having low skeletal muscle mass

New research published in Arthritis & Rheumatology suggests that adults with low blood levels of urate, a breakdown product of metabolism, may be at higher risk of having low skeletal muscle mass and strength and may face a higher risk of early death.

17 Aug 2022

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

First-of-its-kind messenger RNA therapy developed for ovarian cancer, cachexia

Study identifies mechanism behind 'cytokine storm' in COVID-19 patient lungs

What is the risk of SARS-CoV-2 infection among gout patients?

Factors influencing patient’s perception during COVID-19 recovery

Supplementary folic acid associated with higher risk of COVID-19 diagnosis and mortality

Researchers identify protein that plays a critical role in rheumatoid arthritis damage

‘It’s becoming too expensive to live’: Anxious older adults try to cope with limited budgets

Auranofin inhibits SARS-CoV-2 replication

Myocarditis cases among young males after COVID-19 vaccines remain rare and mild, study finds

The origins, breadth, and resolution of autoreactivity in severe COVID-19

Novel method for accurate diagnosis and treatment of uveitis

Is there an association between the gut microbiome of people within different countries and the severity of COVID-19?

People with autoimmune disorder have a higher risk of developing cardiovascular disease

The incidence rates of adverse events of special interest in COVID-19 vaccinated and non-vaccinated persons

Medical cannabis used for chronic pain linked with elevated risk of heart rhythm disorders

New treatment may help counteract food allergies and inflammatory diseases in future

Study reveals safety and uptake of sotrovimab against severe SARS-CoV-2 infection in England

Scientists begin phase 2 clinical trials of lupus pill

Novel member of a class of anti-diabetes drugs could help treat muscle wasting disease

Adults with low blood urate levels may be at higher risk of having low skeletal muscle mass

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in